Harbor BioSciences Inc (HRBR)
OTHER OTC:HRBR
US Market
Holding HRBR?
Track your performance easily

Harbor BioSciences (HRBR) Stock Price & Analysis

18 Followers

HRBR Stock Chart & Stats


Financials

Annual

Ownership Overview

0.00%0.24%0.04%99.72%
0.00%
Insiders
0.04% Other Institutional Investors
99.72% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

HRBR FAQ

What was Harbor BioSciences Inc’s price range in the past 12 months?
Harbor BioSciences Inc lowest stock price was $0.25 and its highest was $2.25 in the past 12 months.
    What is Harbor BioSciences Inc’s market cap?
    Currently, no data Available
    When is Harbor BioSciences Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Harbor BioSciences Inc’s earnings last quarter?
    Currently, no data Available
    Is Harbor BioSciences Inc overvalued?
    According to Wall Street analysts Harbor BioSciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Harbor BioSciences Inc pay dividends?
      Harbor BioSciences Inc does not currently pay dividends.
      What is Harbor BioSciences Inc’s EPS estimate?
      Harbor BioSciences Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Harbor BioSciences Inc have?
      Harbor BioSciences Inc has 54,763,306 shares outstanding.
        What happened to Harbor BioSciences Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Harbor BioSciences Inc?
        Currently, no hedge funds are holding shares in HRBR
        ---

        Company Description

        Harbor BioSciences Inc

        Harbor Diversified, Inc. is a development stage pharmaceutical company, which engages in the discovery, development, and commercialization of products for the treatment of diseases related to aging. The firm focuses on two clinical development products, Apoptone and Triolex. The company was founded on August 15, 1994 and is headquartered in San Diego, CA.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Alpha Pro Tech
        Aptose Biosciences
        Lipocine
        Trevena
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis